Regarding the clinical phenotypes of GPV carriers, the case that shows the GPV in CDKN2A (MH11) exhibits the typical phenotype described for CDKN2A germline mutations—early age at diagnosis, multiple primary melanomas, multiple family members affected, and association with pancreatic cancer [9,10]. This evidence concerns the gene GP5 and melanoma.